Maraviroc

Maureen M. Forrestel, Pharm.D., Paul A. Pham, Pharm.D., Alice Jenh Hsu, Pharm.D.
Maraviroc is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Used in combination with other ARVs in ART-experienced adult patients infected with CCR5 (R5)-tropic HIV-1.
  • Used in combination with other ARVs in ART-naive adult patients infected with CCR5 (R5)-tropic HIV-1 (not a DHHS preferred first line agent)

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Used in combination with other ARVs in ART-experienced adult patients infected with CCR5 (R5)-tropic HIV-1.
  • Used in combination with other ARVs in ART-naive adult patients infected with CCR5 (R5)-tropic HIV-1 (not a DHHS preferred first line agent)

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: September 25, 2015